Insider Trading activities of Biohaven Pharmaceutical Holding Co Ltd. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biohaven Pharmaceutical Holding Co Ltd. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biohaven Pharmaceutical Holding Co Ltd. since year 2005. Table 2 shows the detailed insider transactions of Biohaven Pharmaceutical Holding Co Ltd. since 2005. The reporting company's ticker symbol is BHVN. The reporting company's CIK number is 1689813.
The total value of stock buying since 2005 is $18,131,350.
The total value of stock sales since 2005 is $10,444,446.
The total value of stock option exercises since 2005 is $300,378.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Biohaven Pharmaceutical Holding Co Ltd. (BHVN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 0 $0 275,538 $7,460,746 65,538 $300,378
2017-10 0 $0 100,000 $2,983,700 0 $0
2017-05 1,066,550 $18,131,350 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Biohaven Pharmaceutical Holding Co Ltd. insiders (BHVN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-14 Berman Robert (Chief Medical Officer) Sale 33,664 24.75 833,352
2017-11-13 Berman Robert (Chief Medical Officer) Sale 46,587 25.89 1,205,904
2017-11-10 Berman Robert (Chief Medical Officer) Sale 52,326 26.31 1,376,697
2017-11-10 Engelhart James (Chief Financial Officer) Sale 8,938 26.28 234,890
2017-11-10 Engelhart James (Chief Financial Officer) Option Ex 8,938 .61 5,452
2017-11-09 Berman Robert (Chief Medical Officer) Sale 27,423 26.80 734,799
2017-11-09 Engelhart James (Chief Financial Officer) Sale 21,600 26.82 579,204
2017-11-09 Engelhart James (Chief Financial Officer) Option Ex 21,600 .61 13,176
2017-11-01 Coric Vlad (Chief Executive Officer) Sale 50,000 29.36 1,468,000
2017-11-01 Tilton John (Chief Commercial Officer) Sale 30,000 29.36 880,950
2017-11-01 Tilton John (Chief Commercial Officer) Option Ex 30,000 9.29 278,700
2017-11-01 Gentile Kimberly (VP of Operations) Sale 5,000 29.39 146,950
2017-11-01 Gentile Kimberly (VP of Operations) Option Ex 5,000 .61 3,050
2017-10-31 Coric Vlad (Chief Executive Officer) Sale 100,000 29.84 2,983,700
2017-05-09 Berman Robert (Chief Medical Officer) Buy 50 17.00 850
2017-05-09 Conway Charles (Chief Scientific Officer) Buy 4,000 17.00 68,000
2017-05-09 Engelhart James (Chief Financial Officer) Buy 2,500 17.00 42,500
2017-05-09 Cha Albert (Director) Buy 470,000 17.00 7,990,000
2017-05-09 Bailey Gregory (Director) Buy 175,000 17.00 2,975,000
2017-05-09 Childs John W (Director) Buy 415,000 17.00 7,055,000

Insider trading activities including stock purchases, stock sales, and option exercises of BHVN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biohaven Pharmaceutical Holding Co Ltd. (symbol BHVN, CIK number 1689813) see the Securities and Exchange Commission (SEC) website.